α-吡咯烷基苯庚酮
外观
| 臨床資料 | |
|---|---|
| 其他名稱 | α-PHPP; alpha-PHPP; alpha-Pyrrolidinoheptiophenone; alpha-Pyrrolidinoheptanophenone; PV-8; PV8; Aphpp; A-PHPP |
| 法律規範狀態 | |
| 法律規範 |
|
| 识别信息 | |
| |
| CAS号 | 13415-83-3( 13415-55-9 (盐酸盐) 2304915-38-4 (R) 2304915-72-6 (S)) |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 化学信息 | |
| 化学式 | C17H25NO |
| 摩尔质量 | 259.39 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
α-吡咯烷基苯庚酮(英語:α-Pyrrolidinoheptaphenone,缩写:α-PEP、α-PHPP,或称为:1-苯基-2-(N-吡咯烷基)-1-庚酮、PV8)是一种含氮有机化合物,分子式C17H25NO,属于卡西酮衍生物[1][2],2015年列入《非药用类麻醉药品和精神药品名录》[3]。
参考文献
[编辑]- ^ Minakata K, Yamagishi I, Nozawa H, Hasegawa K, Wurita A, Gonmori K, Suzuki M, Watanabe K, Suzuki O. Determination of new pyrrolidino cathinone derivatives, PVT, F-PVP, MPHP, PV8, PV9 and F-PV9, in human blood by MALDI-Q-TOF mass spectrometry. Forensic Toxicology. 2015, 33: 148–154. S2CID 8271553. doi:10.1007/s11419-014-0248-3.
- ^ Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, Urade Y, Goda Y. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products. Forensic Science International. October 2014, 243: 1–13. PMID 24769262. doi:10.1016/j.forsciint.2014.03.013.
- ^
关于印发《非药用类麻醉药品和精神药品列管办法》的通知. 维基文库. 公安部 国家卫生计生委 食品药品监管总局 国家禁毒办. 24 9 2015 (中文).